コンテンツへスキップ
Merck
  • Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Cancer letters (2014-07-30)
Lei Duan, Brian Danzer, Victor V Levenson, Carl G Maki
要旨

Autophagy is a mechanism of tamoxifen (TAM) resistance in ER-positive (ER+) breast cancer cells. In this study, we showed in ER+ MCF7 cells that 4-hydroxytamoxifen (4OHTAM) induced cellular nitric oxide (NO) that negatively regulates cellular superoxide (O2-) and cytotoxicity. 4OHTAM stimulated LC3 lipidation and formation of monodansylcadaverine (MDC)-labeled autophagic vesicles dependent on O2-. Depletion of NO increased O2- and LC3 lipidation, yet reduced formation of MDC-labeled autophagic vesicles. Instead, NO-depleted cells formed remarkably large vacuoles with rims decorated by LC3. The vacuoles were not labeled by MDC or the acidic lysosome-specific fluorescence dye acridine orange (AO). The vacuoles were increased by the late stage autophagy inhibitor chloroquine, which also increased LC3 lipidation. These results suggest NO is required for proper autophagic vesicle formation or maturation at a step after LC3 lipidation. In addition, 4OHTAM induced O2--dependent activation of ERK, inhibition of which destabilized lysosomes/autolysosomes upon 4OHTAM treatment and together with depletion of NO led to necrotic cell death. These results suggest an essential role for endogenous NO and ERK activation in the completion of pro-survival autophagy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
タモキシフェン, ≥99%
Sigma-Aldrich
4-ヒドロキシタモキシフェン, ≥70% Z isomer (remainder primarily E-isomer)
Sigma-Aldrich
(Z)-4-ヒドロキシタモキシフェン, ≥98% Z isomer
Sigma-Aldrich
ヨウ化プロピジウム, ≥94.0% (HPLC)
Sigma-Aldrich
タモキシフェン クエン酸塩, ≥99%
Sigma-Aldrich
ヨウ化プロピジウム 溶液
Supelco
タモキシフェン, analytical standard
Sigma-Aldrich
ヨウ化プロピジウム, ≥94% (HPLC)
Supelco
4-ヒドロキシタモキシフェン, analytical standard, (E) and (Z) isomers (50:50)
Sigma-Aldrich
アクリジンオレンジ 塩酸塩 溶液, 10 mg/mL in H2O, ≥95.0% (HPLC)
Supelco
4-ヒドロキシタモキシフェン, (E) and (Z) isomers (50:50), analytical standard
タモキシフェン クエン酸塩, European Pharmacopoeia (EP) Reference Standard
タモキシフェン クエン酸塩, European Pharmacopoeia (EP) Reference Standard